The page is the record's research on the issuer — no analyst, no rating, no view. # Protalix BioTherapeutics, Inc. (NYSE: PLX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Protalix BioTherapeutics, Inc. is listed on the NYSE under the ticker PLX, with ISIN US74365A3095 and LEI 549300SDVB3GP4XDFM60. Its security type is Corporate, its segment is not on the record, and its sector is 2836 Biological Products, (No Diagnostic Substances). Its jurisdiction is United States — Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 33 filings in the twelve months to 2026-11-08, on 20 filing days. The filings are 2 agm_egm, 5 corporate_news, 12 directors_dealings, 6 regulatory_filing and 8 results. The median gap between filing days is 13 days. The latest filing is a regulatory_filing dated 2026-10-15, 24 days before the record date. On the NYSE the median filings count is 64.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 3256 issuers. In sector 2836 the median filings count is 65.5, the median cadence gap is 5.5 days and the median latency is 4.0 days across 176 issuers. ## Auditor The auditor of record is Kesselman & Kesselman C.P.A.s, located in Tel Aviv, Israel. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12, and the market's vintage is sealed. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001006281.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NYSE/PLX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1006281/000110465926029858/plx-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/PLX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/PLX · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp